510(k) K213836

Intracept Intraosseous Nerve Ablation System by Relievant Medsystems, Inc. — Product Code GXI

K213836 is an FDA 510(k) premarket notification submitted by Relievant Medsystems, Inc. for the device "Intracept Intraosseous Nerve Ablation System". The FDA issued a decision of Substantially Equivalent on Mar 11, 2022. The device falls under product code GXI (Probe, Radiofrequency Lesion), a Class II device regulated under 21 CFR 882.4725. Relievant Medsystems, Inc. has 9 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Mar 11, 2022
Date Received
Dec 9, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Probe, Radiofrequency Lesion
Device Class
Class II
Regulation Number
882.4725
Review Panel
NE
Submission Type
510(k)

Need the full FDA record for Relievant Medsystems, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K213836. Report a data issue: hello@regdatalab.com.